ask="32.46"
ask_size="100"
average_daily_volume="299327"
bid="N/A"
bid_size="N/A"
book_value="6.19"
change="-0.03"
change_from_200_day_moving_average="1.57"
change_from_50_day_moving_average="0.85"
change_from_52_week_high="-6.66"
change_From_52_week_low="18.67"
change_in_percent="-0.09%"
close="32.26"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.06"
ebitda="-175.77M"
eps_estimate_current_year="-3.83"
eps_estimate_next_quarter="-1.03"
eps_estimate_next_year="-3.92"
ex_dividend_date="N/A"
float_shares="31720000"
high="32.48"
high_52_weeks="38.92"
last_trade_date="2/14/2017"
last_trade_price="32.26"
last_trade_size="13377"
last_trade_time="4:00pm"
low="32.01"
low_52_weeks="13.59"
market_capitalization="1.68B"
moving_average_200_day="30.69"
moving_average_50_day="31.41"
name="Theravance Biopharma
Inc."
notes="N/A"
one_year_target_price="34.71"
open="32.15"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+5.10%"
percent_change_from_50_day_moving_average="+2.70%"
percent_change_from_52_week_high="-17.11%"
percent_change_from_52_week_low="+137.38%"
previous_close="32.29"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.21"
price_per_sales="35.80"
revenue="46.85M"
shares_outstanding="51942000"
short_ratio="19.05"
stock_exchange="NGM"
symbol="TBPH"
volume="133267"
weeks_range_52="13.59 - 38.92"
